The whole blood which is a mixture of cells, colloids and crystalloids can be separated into different blood components namely packed red blood cell (PRBC) concentrate, platelet concentrate, fresh frozen plasma and cryoprecipitate. Each blood component is used for a different indication; thus the component separation has maximized the utility of one whole blood unit. Different components need different storage conditions and temperature requirements for therapeutic efficacy. A variety of equipment to maintain suitable ambient conditions during storage and transportation are in vogue. The blood components being foreign to a patient may produce adverse effects that may range from mild allergic manifestations to fatal reactions. Such reactions are usually caused by plasma proteins, leucocytes, red cell antigens, plasma and other pathogens. To avoid and reduce such complications, blood products are modified as leukoreduced products, irradiated products, volume reduced products, saline washed products and pathogen inactivated products. The maintenance of blood inventory forms a major concern of blood banking particularly of rare blood groups routinely and common blood groups during disasters. PRBCs can be stored for years using cryopreservation techniques. New researches in red cell cultures and blood substitutes herald new era in blood banking.
Download Sample : https://www.alliedmarketresearch.com/request-sample/11256
Covid-19 Scenario analysis:
COVID-19 is an extremely infectious disease caused by the Coronavirus. Symptoms and conditions of the disease include mild to moderate respiratory discomfort. While most may recover without any need for special treatment, the virus can cause major issues or serious illness and even death in older individuals and persons with underlying medical problems such as diabetes, cardiovascular disease, chronic respiratory diseases, and cancers. The virus is spread from animals to humans, and thereafter from humans to humans. Coronavirus strains have been the cause of numerous deaths, and infections in the past. Outbreaks have been increasingly more regular over the past few decades, and there is an urgent need for accurate diagnostic methods for the coronavirus. The plasma therapy, called convalescent plasma treatment, requires blood plasma donations from people who have recovered from Covid-19.This plasma is administered to Covid-19 patients who could not generate sufficient antibodies against the virus so the need for blood preparation i.e. Plasma is need and will boost market growth.
The growing demand for blood transfusion, highly needed blood during surgical procedures and increasing number of blood disorders to make up for extreme blood loss are stimulating the growth in blood preparation market. Increasing blood disorder prevalence and rising emergency surgeries in hospitals also expected to drive the market through the forecast period. Further, increased acceptance of advanced blood testing technologies has accelerated accurate diagnosis of hematological disorders. Other factors including growing demand for blood and its component due to the increase in target diseases, accidents, and surgeries is expected to drive the market for blood preparation market through the forecast period. In addition, growing emergency cases in the emergency departments coupled with rising demand for blood transfusion is expected to fuel the global blood preparation market growth. One of the primary factors which can obstruct the market growth is the high risk of blood transmission disease such as viral hemorrhagic fever, Hepatitis B and HIV.
Request Customization : https://www.alliedmarketresearch.com/request-for-customization/11256
Restraints:
During blood transfusion, the chances of transmission of diseases such as viral hemorrhagic fever, HIV, and Hepatitis B are high. This is the single major restraining factor impacting the growth of the global blood preparation market. Also increasing incidence of allergic reactions at the time of blood transfusion such as hypotensive transfusion reaction is another factor hampering growth of the global blood preparation market over the forecast period.
Key segments covered:
Product Type
- Whole Blood
- RBC
- Plasma
- Platelets
- Blood Components
- Whole Blood Components
- Packed Red Cells
- Leukocyte Reduced Red Blood Cells
- Frozen Plasma
- Platelet Concentrate
- Cryoprecipitate
- Blood Derivatives
Application
- Hospitals
- Clinics
- Diagnostic centers
- Research Labs
- Blood banks
- Pharmaceuticals
- Others
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/11256
Other Healthcare Reports
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5305,
UK: +44-845-530-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975